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Background: Acute disseminated encephalomyelitis (ADEM) is an autoimmune disease that typically follows a
monophasic course and may affect any age group. The precise population-based incidence of ADEM is still
unknown in most countries. In China, there is no ADEM surveillance system. The exact incidence of ADEM is difficult
to estimate, and other epidemiological characteristics of ADEM are unknown. The purpose of this study is to
investigate the epidemiological characteristics of ADEM in Nanchang, China.
Methods: A retrospective investigation was conducted with ADEM patients admitted to second-level and
third-level hospitals in Nanchang from 2008 to 2010, aiming to analyse the epidemiologic characteristics of ADEM
in the population in Nanchang. ADEM patients, defined as patients who were diagnosed according to the
consensus definition of ADEM provided by the International Pediatric MS Study Group, were enrolled in the study.
The data were extracted from the ADEM patients’ medical records.
Results: Forty-seven ADEM patients were investigated. The average annual incidence was 0.31/100,000; the
incidence among males (0.31/100,000) was nearly equal to that among females (0.31/100,000). The median age of
onset was 25.97 years old, and the peak incidence was observed in the 5- to 9-year-old age group (0.75/100,000),
followed by the over-60 age group (0.55/100,000). ADEM occurs throughout the year, but it occurs most frequently
in March (n = 7) and least frequently in April and July (both n = 2). The patient numbers are roughly even in the
other months. In the 2 months before the onset of ADEM, 15 patients presented with a preceding infection, but
none of the patients received a vaccination. An increased number of vaccination was not accompanied by a
corresponding increased number of cases of ADEM.
Conclusions: The average annual incidence of ADEM was 0.31/100,000 in Nanchang. The incidence among males
was nearly equal to that among females. The peak age of onset was 5–9 years old. The peak season of onset was
not apparent. There was no evidence of an association between increased number of vaccines administered and
number of cases of ADEM in Nanchang, China.
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Acute disseminated encephalomyelitis (ADEM) is a dis-
ease that is mainly characterised by an inflammatory reac-
tion and demyelination of the central nervous system
(CNS) [1]. ADEM, which typically follows a monophasic
course, may occur in any age group, especially in children,* Correspondence: yanyan@csu.edu.cn
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It usually occurs in winter and has no unified diagnostic
criteria [2-5]. Some researchers have noted that the inci-
dence rates of ADEM are not different between genders,
races, and regions [6,7]. The pathogenesis of ADEM is not
fully known, but adhesion molecules, chemokines, matrix
metalloproteinase, and other cell factors can play import-
ant roles in its occurrence and development [8].td. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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exanthematous disease) or vaccination (e.g., rabies, small
pox or measles vaccines) [4,9] and primarily affects the
white matter of the brain and the spinal cord [10,11].
The precise annual population-based incidence is un-
known, but it is estimated to be 0.8/100,000 [12]. The
mean age of onset ranges from 5 to 8 years old [13,14];
the incidence of ADEM in children is higher than in
adults. Older patients are rarely reported [15]. There is
no clear research on the global distribution of ADEM. In
Fukuoka Prefecture, Japan, the annual incidence of
ADEM in children under 15 years old was 0.64/100,000,
the mean age of onset was 5.7 years old, and the inci-
dence in males was 2.3 times higher than in females
[16]. ADEM occurs more frequently in the winter and in
the spring.
In China, there has been little research about the inci-
dence of ADEM, and the exact incidence of ADEM is
still difficult to estimate. To understand the epidemio-
logic characteristics of ADEM in Nanchang in Jiangxi
Province, China, a retrospective investigation of the
ADEM patients admitted to all hospitals in 2008–2010
was performed at the end of 2011.
Methods
Jiangxi is situated in central China, and Nanchang, the
capital city, is the centre of Jiangxi politics, economy,
cultures and health services. There is a population of
4,981,054 in Nanchang (average from 2008 to 2010). In
the Chinese health service system, hospitals are divided
into three levels. The higher-level hospitals have greater
medical service capabilities. First-level hospitals are basic
hospitals and primary health care institutions that
mainly provide primary prevention services to commu-
nity residents or referrals for serious or rare diseases.
The second-level hospitals are regional hospitals and re-
gional medical prevention technology centres. Their
main functions include disease treatment, acceptance of
referrals and technical guidance for medical services
provided by primary hospitals. Third-level hospitals are
general hospitals with the greatest ability to provide
comprehensive medical treatment and to engage in
teaching and scientific research, especially treatment of
serious and rare diseases.
There are 35 second-level and third-level hospitals in
Nanchang. Of these, 16 hospitals are third-level hospitals
with the highest level of medical services in Jiangxi; they
possess over 15,000 beds and provide advanced medical
services. The 19 remaining hospitals are second-level
hospitals. There are 263 first-level hospitals, which pro-
vide lower-level medical services. Most first-level hospi-
tals do not even have medical beds, so they are
incapable of diagnosing and treating severe illnesses
(e.g., ADEM). Severely ill patients who are admittedthere will be transferred to the second-level or top-level
hospitals. Therefore, the patients admitted by second–
level and third-level hospitals comprise all the cases of
ADEM in Nanchang and reflect the actual incidence of
ADEM in Nanchang.
We approached and sought help from local health
administration authorities (i.e., Jiangxi Provincial Health
Department and Nanchang City Health Bureau) in ad-
vance, so the study was conducted successfully. We inves-
tigated all ADEM cases admitted by the 35 second-level
and third-level hospitals in Nanchang from 2008 to 2010.
All the cases were identified from the electronic medical
records information management system (EMRIMS) in
each hospital using the consensus definitions of ADEM
that were proposed by the International Pediatric MS
Study Group. The definition of ADEM was based on the
criteria described below [17].
The infection symptoms appear first. It occurs acutely
or subacutely and indicates that an illness is severe or
dangerous.
With regard to the clinical presentation, the brain or
spinal cord usually suffers multifocal damage. The cere-
bral symptoms are predominantly mental symptoms,
disturbances of consciousness and meningeal irritation;
pyramidal tract and cerebellar signs can appear. The my-
elopathic symptoms include paraplegia, rising palsy and
urinary disorders, etc.
The cerebrospinal fluid (CSF) pressure is normal or
higher, CSF-monocytes rise, immunoglobulin G rises, and
the electroencephalo-graph is abnormal. Computed tom-
ography (CT) and magnetic resonance imaging (MRI)
show scattered lesions on the brain and spinal cord.
Professional and technical personnel manually
searched the cases using the same criteria without
EMRIMS, and then a senior neurologist checked the
search results. The investigator collected relevant data
from the medical records of the searched cases and sup-
plemented some data at the grassroots level using vac-
cination records and information from the patients’
family members. During the investigation, if the same
case was diagnosed and cured many times in the same
hospital, the results depended on the hospitalisation re-
cords and the discharge diagnoses. If the same case was
diagnosed and cured in different hospitals, the results
depended on the medical records and discharge diagno-
sis at the upper-level hospital. The same patients who
were seen repeatedly were considered new cases each
time.
Data collection
The following data were extracted from the patients’
medical records: gender, date of birth, residential area,
rural or urban residence, occupation, marital status, date
of onset and allergic history, family medical history,
Xiong et al. BMC Public Health 2014, 14:111 Page 3 of 6
http://www.biomedcentral.com/1471-2458/14/111childbirth history, and disease history within 2 months
before the onset of ADEM.
The data on the total population of Nanchang from
2008 to 2010 were acquired from the Nanchang City
Statistic Bureau. The vaccination data for Nanchang
from 2008 to 2010 were obtained from the Nanchang
City Center for Disease Control and Prevention.
Data analysis
The survey data were input into Chinese version EpiData
3.1 (270108) and Microsoft Office Excel 2003s. IBM SPSS
20 was used to check, sort and analyse the data and to cal-
culate the age- and gender-adjusted incidence rates in the
total population of Nanchang. The incidence rates were
compared by year, gender and composition ratio using the
chi-square test. The assumed distribution of a single sam-
ple was tested with the Kolmogorov-Smirnov test. All of
the tests were two-sided, and 0.05 was the level of
significance.
Ethics statement
This investigation was ratified by the Ethics Committee
of Nanchang City Center for Disease Control and Pre-
vention (Reference number 2011002). The participants
wrote Informed Consent. The relevant data were ex-
tracted from the medical records, and no case specimens
were collected. All the data were analysed anonymously.
The patients’ private information was safeguarded
effectively.
Results
Forty-seven cases of ADEM were identified and investi-
gated: 44 from third-level hospitals and 3 from second-
level hospitals. The average annual incidence was 0.31/
100,000 in 2008–2010 (Table 1). The incidence rates of
ADEM changed insignificantly from year to year. There
were as many male cases as female cases, with no signifi-
cant difference between the genders. The incidence
among males (0.31/100,000) was almost equal to the in-
cidence among females (0.32/100,000), with no signifi-
cant difference.Table 1 Overall incidence and gender-based incidence of ADE
Year Male Female Total population Male case
(n) (n) (n)
2008 2,599,218 2,348,048 4,947,266 11
2009 2,607,689 2,365,636 4,973,325 7
2010 2,625,446 2,397,124 5,022,570 6
Sum 7,832,353 7,110,808 14,943,161 24
Chi-square 3
P 0The mean age of onset was 33.40 years old (95% confi-
dence interval (CI) 26.34 to 40.45), and the median age
was 25.97 years old. Table 2 indicates the incidences in dif-
ferent age groups. The incidence was the highest in chil-
dren 5 to 9 years old (0.75/100,000), followed by
individuals over 60 years old (0.55/100,000), but there
were no significant differences between the age groups
(χ2 = 15.392, P = 0.052). The average annual incidence was
0.47/100,000 in children under 15 years old (n = 16) and
0.27/100,000 in those over 15 years old; the difference be-
tween children and adults was not significant (χ2 = 3.460,
P = 0.063).
Of the 47 patients, 31 patients were over 15 years old,
and 3 patients were under 3 years old.
There are 56 nationalities in China. The Han nationality
is the most common. All 47 of the patients were the Han
nationality. With regard to occupation, students (from
university and schools) (n = 13) and peasants (n = 13) were
the most common roles. Of the 31 patients older than
15 years old, 26 (83.87%) were married.
The 47 patients were distributed uniformly throughout
the year in terms of the onset time (P = 0.188). Figure 1 in-
dicates that the peak month of onset was March (n = 7,
14.89%), and the nadir month of onset was April (n = 2)
or July (n = 2). In the comparison of the onset time distri-
butions between the genders, the expected values for all
the cells were less than 5, so the 12 months were divided
into four quarters (January to March, April to June, July to
September, and October to December). Then, 16, 9, 9 and
13 of the 47 cases were included in the first, second, third
and fourth quarters, respectively. However, 50% of the ex-
pected cell values were less than 5 when a comparison
was made between the genders, and 83.3% of the expected
cell values were less than 5 when a comparison was made
between years.
Table 3 shows whether the patients fell ill or not within
two months before the onset of disease. Fifteen patients
had a history of preceding illness. There was no signifi-
cant difference between the genders (χ2 = 0.170, P =
0.680) or between the years (χ2 = 2.717, P = 0.257). In this
study, all 15 patients who fell ill within 2 months before
the onset (6 cases: < 14 years old; 5 cases: 15–59 yearsM in Nanchang
Female case Total case Incidence (1/100,000)
(n) (n) In males In females Overall
5 16
7 14 0.27 0.30 0.28
11 17 0.23 0.46 0.34
23 47 0.31 0.32 0.31
.701 0.034 0.276
.157 0.853 0.871
Table 2 Age-based incidence of ADEM in Nanchang
Age
group
Population Case Average annual incidence
n n (1/100,000)
0- 1,054,987 3 0.28
5- 1,069,930 8 0.75
10- 1,264,191 5 0.40
15- 1,129,703 3 0.27
20- 1,673,634 5 0.30
30- 2,665,860 2 0.08
40- 2,359,525 6 0.25
50- 1,921,691 5 0.26
60- 1,803,640 10 0.55
Total 14,943,161 47 0.31
Table 3 Falling ill or not within 2 months before the
onset of ADEM
Male Female 2008 2009 2010
being ill 7 8 7 5 3
Not being ill 17 15 9 9 14
Total 24 23 16 14 17
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fection and had symptoms of a respiratory tract infection.
Among the 15 patients, 7 patients were given an antigen
antibody test. One patient had the Epstein-Barr virus and
Coxsackie virus, 2 patients had cytomegalovirus, 1 pa-
tient had cytomegalovirus and herpes simplex virus, 1 pa-
tient had Gram-positive bacteria, and three patients
received negative results. Among the 15 patients, 2 pa-
tients had co-morbid chronic bronchitis, 1 patient had
severe pneumonia, and 1 patient had high blood
pressure.
The study showed that no patients were vaccinated
within two months before the onset of disease.
The results of ecological study on the relationship be-
tween vaccines and ADEM are shown below. The situ-
ation of immunisation vaccine campaigns in Nanchang
during 2008–2010 were as follows: in 2008, there were
1,535,873 routine immunisation doses administered to
the total population; in 2009, a supplementary immun-
isation campaign for the measles vaccine and a revaccin-
ation campaign for the hepatitis B vaccine for children
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Figure 1 Monthly distribution of the onset of the 47 ADEM cases.3,686,817 total vaccination doses; in 2010, a supplemen-
tary immunisation campaign for the measles vaccine for
children under 4 years old, a revaccination campaign for
the oral poliovirus vaccine, and a revaccination cam-
paign for the hepatitis B vaccine for children under
15 years old were conducted for a total of 3,274,689
doses. The number of vaccination administered in 2009
was 2.40 times higher than the number administered in
2008, while the number of ADEM patients decreased by
2. The number of vaccination administered in 2010 was
2.13 times higher than the number administered in
2008, but the number of ADEM patients in 2010 was
only one more than the number in 2008.
Discussion
This study was the first large-scale investigation of
ADEM incidence in Nanchang, Jiangxi in China, and it
could help us to understand the baseline ADEM inci-
dence in Nanchang. The investigation showed that the
average annual incidence of ADEM in Nanchang was
0.31/100,000, which is slightly lower than the incidence
in San Diego between 1991–2000 (0.4/100,000), than the
incidence among children with demyelination disease in
Thailand between 1997–2006 (4.1/100,000) [18], and
then an estimation of 0.8/100,000 [12]. However, the in-
cidence was higher than the incidence among Germans
(0.07/100,000) [19]. These results indicate that the inci-
dence rates of ADEM differ among countries, most
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was 33.40, and the median age was 25.97. The incidence
was 0.55/100,000 among those over 60 years old, 0.47/
100,000 among those under 14 years old, and 0.27/
100,000 among those 15–59 years old. The incidence rate
was 0.31/100,000 among males and 0.32/100,000 among
females. Reportedly, ADEM mainly occurs in children
younger than 10 years old [3,4] or mainly in children and
young people [20]. Previous studies on ADEM have fo-
cused on children but rarely on adults. Among the chil-
dren with demyelination disease in Thailand between
1997 and 2006, the incidence rate was 4.1/100,000, the
average age of onset was 6.9 years old, and most of the pa-
tients presented with a preceding infection [18]. In
Germany, the incidence rate of ADEM was 0.09/100,000
among children under 10 years old and 0.03/100,000
among children 10–15 years old. Thus, children 3–8 years
old were the peak group of onset; the incidence rate was
insignificantly higher in males than in females [19]. Ban-
well reported that ADEM mostly attacked children under
10 years old, but the incidence rates did not differ between
the sexes [21], and the median age of onset was 6.5 [1].
The results of our study are similar to some other studies
in the literature: ADEM may occur in any age group, and
the incidence rate is insignificantly higher among children
under 14 years old than among people older than 15 years
old. The incidence rate is the highest among children 5–9
years old (0.75/100,000), followed by individuals older
than 60 years old (0.55/100,000). Senile ADEM has rarely
been reported [15], which attracts our attention.
ADEM occurs most frequently in March (n = 7) and
least frequently in April or July (both n = 2). It is easier for
the residents to become infected with a precursor disease,
such as a respiratory tract infection, because of the winter
weather in Nanchang. In the northern hemisphere sub-
tropical zone, it is coldest in January and February. In
addition, the Chinese spring festival, the most important
traditional festival in China, is often around February.
People are often reluctant to go to hospital until spring
festival is over. Thus, the number of patients may increase
in March. When the 12 months were divided into 4 sea-
sons, the incidence rates did not differ by season. This
conclusion is slightly different from the conclusion that
ADEM occurs more frequently in the spring and in the
winter [6,22]. Preceding infections generally occur 2 to 60
days before the onset of ADEM [3,23]; two-thirds of the
child patients had a preceding infection, one-sixth of the
child patients had a history of inoculation [16], and ap-
proximately 50% of the adult patients had no preceding
infection. The viruses that cause infection mainly include
measles, parotitis, urticaria, varicella-zoster virus, cyto-
megalovirus (CMV), Epstein-Barr virus, herpes simplex
virus, hepatitis A or B, Coxsackie virus, influenza A or B,
HIV, human T-cell lymphotropicvirus-1 (HTLV-1), humanherpes virus 6 [24], and the bacteria are mainly pneumo-
nia mycoplasma [25]. In this study, 15 patients (31.92%)
had other diseases before the onset of ADEM (all were
preceding infections); 6 patients under 14 years old
(37.5%) and 4 patients older than 60 years old (40%) had
preceding infections. The detected rates of infection with
pathogens were consistent with previous studies.
ADEM often occurs after vaccination, so it is believed
that ADEM related to inoculation most likely occurs be-
cause the inoculation induces autoimmune disorders that
cause brain and spinal cord immune injuries. Inoculation
with vaccines against hydrophobia (in particular), small-
pox or measles [26], poliomyelitis [27], type-B encephalitis,
hepatitis B, pertussis, or influenza can cause ADEM, but
cases caused by the influenza vaccine are rarely reported
[24,28]. With vaccination, the total incidence rate of
ADEM was 0.1-0.2/100,000 [12], lower than the incidence
rate after infection with the measles virus (1:1,000) [29].
The incidence of ADEM was 1:1,000 - 1:20,000 after in-
oculation with the measles vaccine and 1:7,000-1:50,000
after inoculation with the rabies vaccine [30]. Only one of
the 14.3 million inoculators in Sichuan, China in 2007–
2008 had ADEM. The results of the study showed that no
patients received a vaccination within 2 months before the
onset of ADEM. In addition, the results of ecological study
showed that an increased number of vaccination was not
accompanied with a corresponding increased number of
cases of ADEM. Because ecological study has some main
limitations including ecological fallacy and difficult control
of some confounding factors etc. The results of ecological
study cannot provide strong evidence for an association
between exposed factors and onset of the disease. Thus,
the authors inferred discreetly the following conclusion
with the existing research data: there was no evidence of
an association between increased number of vaccines ad-
ministered and number of cases of ADEM in Nanchang,
China. It would be satisfactory if a cohort study on the as-
sociation between vaccine and ADEM was performed.
In this study, the authors searched all the hospitals
that could receive and cure ADEM patients, but some
ADEM patients might not go to hospital. Some ADEM
patients might have been missed, so the incidence of
ADEM might be underestimated. The information in the
medical records might be incomplete, and information
bias might be present.
Conclusions
The average annual incidence of ADEM was 0.31/100,000
in Nanchang. The incidence rates were nearly equal be-
tween genders. The high-risk age group is 5–9 years old.
There was no seasonal variation in the incidence of
ADEM. There was no evidence of an association between
increased number of vaccines administered and number
of cases of ADEM in Nanchang, China.
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